Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
This is the first update to the original CTS communication distributed on July 6th. As previously co...